Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial.

Mulder, Gerit

Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial. [electronic resource] - Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society - 772-9 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

1524-475X

10.1111/j.1524-475X.2009.00541.x doi


Adenoviruses, Human--genetics
Administration, Topical
Adult
Aged
Bandages, Hydrocolloid
Debridement
Diabetic Foot--drug therapy
Drug Dosage Calculations
Female
Gels
Genetic Therapy
Humans
Male
Middle Aged
Proto-Oncogene Proteins c-sis--administration & dosage
Wound Healing